These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14629156)

  • 1. Modification of 1-substituents in the 2-azabicyclo[2.1.1]hexane ring system; approaches to potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives.
    Malpass JR; Patel AB; Davies JW; Fulford SY
    J Org Chem; 2003 Nov; 68(24):9348-55. PubMed ID: 14629156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-substituted 2-azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn-and anti-isoepiboxidine.
    Malpass JR; White R
    J Org Chem; 2004 Aug; 69(16):5328-34. PubMed ID: 15287778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives.
    Patel AB; Malpass JR
    J Med Chem; 2008 Nov; 51(21):7005-9. PubMed ID: 18841955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to syn-7-substituted 2-azanorbornanes as potential nicotinic agonists; synthesis of syn- and anti-isoepibatidine.
    Malpass JR; Handa S; White R
    Org Lett; 2005 Jun; 7(13):2759-62. PubMed ID: 15957940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex-induced proximity effects. Temperature-dependent regiochemical diversity in lithiation-electrophilic substitution reactions of N-BOC-2-azabicyclo[2.1.1]hexane. 2,4- and 3,5-methanoprolines.
    Krow GR; Herzon SB; Lin G; Qiu F; Sonnet PE
    Org Lett; 2002 Sep; 4(18):3151-4. PubMed ID: 12201739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of azabicyclo[2.2.n]alkane systems as analogues of 3-[1-methyl-2-(S)-pyrrolidinyl- methoxy]pyridine (A-84543).
    Carreras J; Avenoza A; Busto JH; Peregrina JM
    J Org Chem; 2007 Apr; 72(8):3112-5. PubMed ID: 17371077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine.
    Carroll FI; Robinson TP; Brieaddy LE; Atkinson RN; Mascarella SW; Damaj MI; Martin BR; Navarro HA
    J Med Chem; 2007 Dec; 50(25):6383-91. PubMed ID: 17994682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new bridgehead substituted azabicyclo-[2.2.1]heptane and -[3.3.1]nonane derivatives as potent and selective α7 nicotinic ligands.
    Slowinski F; Ben Ayad O; Vache J; Saady M; Leclerc O; Lochead A
    Org Lett; 2010 Nov; 12(21):5004-7. PubMed ID: 20939603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epibatidine structure-activity relationships.
    Carroll FI
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of 8-azabicyclo[3.2.1]octane benzylamine NK1 antagonists.
    Thomson CG; Carlson E; Chicchi GG; Kulagowski JJ; Kurtz MM; Swain CJ; Tsao KL; Wheeldon A
    Bioorg Med Chem Lett; 2006 Feb; 16(4):811-4. PubMed ID: 16307878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine.
    Che D; Wegge T; Stubbs MT; Seitz G; Meier H; Methfessel C
    J Med Chem; 2001 Jan; 44(1):47-57. PubMed ID: 11141087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
    Ji J; Schrimpf MR; Sippy KB; Bunnelle WH; Li T; Anderson DJ; Faltynek C; Surowy CS; Dyhring T; Ahring PK; Meyer MD
    J Med Chem; 2007 Nov; 50(22):5493-508. PubMed ID: 17929796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted 2-azabicyclo[2.1.1]hexanes as constrained proline analogues: implications for collagen stability.
    Jenkins CL; Lin G; Duo J; Rapolu D; Guzei IA; Raines RT; Krow GR
    J Org Chem; 2004 Dec; 69(25):8565-73. PubMed ID: 15575731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of bicyclic proline derivatives by the aza-Cope-Mannich reaction: formal synthesis of (±)-acetylaranotin.
    Belov DS; Ratmanova NK; Andreev IA; Kurkin AV
    Chemistry; 2015 Mar; 21(10):4141-7. PubMed ID: 25631763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aza-Quaternary Scaffolds from Selective Bond Cleavage of Bridgehead-Substituted 7-Azabicyclo[2.2.1]heptane: Total Synthesis of (+)-Cylindricines C-E and (-)-Lepadiformine A.
    Pandey G; Janakiram V
    Chemistry; 2015 Sep; 21(37):13120-6. PubMed ID: 26220441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective syntheses of (+/-)-epibatidine analogues.
    Kim YH; Won DY; Oh CY; Lee KY; Lee YS; Woo NT; Park YH; Park HJ; Ham WH
    Arch Pharm Res; 2002 Feb; 25(1):45-8. PubMed ID: 11885690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aza-Prins-pinacol approach to 7-azabicyclo[2.2.1]heptanes: syntheses of (+/-)-epibatidine and (+/-)-epiboxidine.
    Armstrong A; Bhonoah Y; Shanahan SE
    J Org Chem; 2007 Oct; 72(21):8019-24. PubMed ID: 17867705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of heterocyclic analogues of epibatidine via 7-azabicyclo[2.2.1]hept-2-yl radical intermediates. 1. Intermolecular reactions.
    Gómez-Sánchez E; Soriano E; Marco-Contelles J
    J Org Chem; 2008 Sep; 73(17):6784-92. PubMed ID: 18656981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiospecific synthesis of annulated nicotine analogues from D-glutamic acid. 7-Azabicyclo[2.2.1]heptano[2.3-c]pyridines.
    Lennox JR; Turner SC; Rapoport H
    J Org Chem; 2001 Oct; 66(21):7078-83. PubMed ID: 11597233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. aza-Prins-pinacol approach to 7-azabicyclo[2.2.1]heptanes and ring expansion to [3.2.1]tropanes.
    Armstrong A; Shanahan SE
    Org Lett; 2005 Mar; 7(7):1335-8. PubMed ID: 15787500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.